๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-04-21

Circulating Tumor Cells (CTC) in Lung Cancer (NCT02630615)

๐Ÿ”ต Active, Not Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: Shadia Jalal

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The primary objective of this study is to establish circulating tumor cell (CTC) derived xenografts and assess the activity of novel DNA repair inhibitors as a function of DNA repair mutations detected in CTC samples (personalize DNA repair therapy).

Who can join: Review the eligibility criteria below.

Location: Indiana University Health Melvin and Bren Simon Cancer Center โ€” Indianapolis, Indiana

Age range: 18 Years

๐Ÿงช Interventions in This Study

  • Blood draw (OTHER)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (2 Sites)

  • Indiana University Health Melvin and Bren Simon Cancer Center โ€” Indianapolis, Indiana
  • Roudebush VA Medical Center โ€” Indianapolis, Indiana

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Lung Neoplasms clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—